# RARE (Ultragenyx Pharmaceutical Inc.) - SEC EDGAR Financial Statements

> Ultragenyx Pharmaceutical Inc. reported $730.0M in revenue and a net loss of $524.0M for the trailing twelve months ended September 30, 2026 (up 8.1% year over year), with a -64.0% operating margin.

- Canonical: https://convexityos.com/fundamentals/RARE
- Markdown: https://convexityos.com/fundamentals/RARE.md
- SEC CIK: 0001515673
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 20, 2026, 05:25 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001515673&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | TTM | $730.0M | +8.1% YoY |
| Operating Income | TTM | -$467.0M | -64.0% margin |
| Net Income | TTM | -$524.0M | -71.8% net margin |
| Diluted EPS | TTM | -$5.13 | Split-adjusted |
| Free Cash Flow | TTM | -$442.0M | -60.5% FCF margin |
| Cash & ST Investments | Sep 30, 2026 | $266.0M | Total debt: -- |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $673.0M | $560.0M | $434.0M | $363.3M | $351.4M | $271.0M | $103.7M | $51.49M | $2.61M | $133K |
| Cost of Revenue | -- | -- | -- | -- | -- | -- | -- | $1.15M | $1.0K | -- |
| **Gross Profit** | -- | -- | -- | -- | -- | -- | -- | $50.35M | $2.61M | -- |
| Research & Development | $750.0M | $698.0M | $648.0M | $705.8M | $497.2M | $412.1M | $357.4M | $294.0M | $231.6M | $183.2M |
| Selling, General & Admin | $349.0M | $321.0M | $310.0M | $278.1M | $220.0M | $182.9M | $161.5M | $127.7M | $99.91M | $64.94M |
| Total Operating Expenses | -- | -- | -- | -- | -- | $601.1M | $527.9M | $422.9M | $331.6M | $248.1M |
| **Operating Income** | -$535.0M | -$536.0M | -$569.0M | -$648.9M | -$381.7M | -$330.1M | -$424.2M | -$371.4M | -$328.9M | -$248.0M |
| **EBITDA** | -$500.0M | -$500.0M | -$543.0M | -$630.7M | -$368.5M | -$317.9M | -$415.6M | -$351.8M | -$323.1M | -$244.6M |
| Interest Income | $25.00M | $37.00M | $27.00M | $11.07M | $1.93M | $7.04M | $13.24M | $9.54M | $4.07M | $3.79M |
| Income Before Tax | -$571.0M | -$567.0M | -$609.0M | -$701.7M | -$453.0M | -$185.4M | -$399.4M | -$197.1M | -$318.3M | -$245.8M |
| Income Tax Expense | $4.00M | $2.00M | -$2.00M | $5.70M | $1.04M | $1.21M | $3.28M | $514K | -$16.20M | $35K |
| **Net Income** | -$575.0M | -$569.0M | -$607.0M | -$707.4M | -$454.0M | -$186.6M | -$402.7M | -$197.6M | -$302.1M | -$245.9M |
| Basic EPS | -$5.83 | -$6.29 | -$8.25 | -$10.12 | -$6.70 | -$3.07 | -$7.12 | -$3.97 | -$7.12 | -$6.21 |
| **Diluted EPS** | -$5.83 | -$6.29 | -$8.25 | -$10.12 | -$6.70 | -$3.07 | -$7.12 | -$3.97 | -$7.12 | -$6.21 |
| Basic Shares Outstanding | 98.6M | 90.5M | 73.5M | 69.9M | 67.8M | 60.8M | 56.6M | 49.8M | 42.5M | 39.6M |
| Diluted Shares Outstanding | 98.6M | 90.5M | 73.5M | 69.9M | 67.8M | 60.8M | 56.6M | 49.8M | 42.5M | 39.6M |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $173.0M | $214.0M | $136.0M | $207.0M | $160.0M | $167.0M | $139.0M | $164.6M |
| Research & Development | $154.0M | $167.0M | $187.0M | $203.0M | $216.0M | $165.0M | $166.0M | $187.9M |
| Selling, General & Admin | $97.00M | $88.00M | $88.00M | $88.00M | $87.00M | $87.00M | $87.00M | $81.89M |
| **Operating Income** | -$110.0M | -$75.00M | -$169.0M | -$113.0M | -$171.0M | -$108.0M | -$143.0M | -$122.3M |
| **EBITDA** | -$101.0M | -$67.00M | -$161.0M | -$104.0M | -$163.0M | -$99.00M | -$134.0M | -$112.8M |
| Interest Income | $3.00M | $5.00M | $6.00M | $6.00M | $6.00M | $6.00M | $7.00M | $10.04M |
| Income Before Tax | -$127.0M | -$91.00M | -$184.0M | -$128.0M | -$179.0M | -$114.0M | -$150.0M | -$132.8M |
| Income Tax Expense | -$9.00M | $1.00M | $1.00M | $1.00M | $1.00M | $1.00M | $1.00M | $384K |
| **Net Income** | -$118.0M | -$92.00M | -$185.0M | -$129.0M | -$180.0M | -$115.0M | -$151.0M | -$133.2M |
| Basic EPS | -$1.16 | -$0.90 | -$1.84 | -- | -$1.81 | -$1.17 | -$1.57 | -- |
| **Diluted EPS** | -$1.16 | -$0.90 | -$1.84 | -- | -$1.81 | -$1.17 | -$1.57 | -- |
| Basic Shares Outstanding | 102.1M | 101.9M | 100.6M | -- | 99.8M | 98.5M | 96.3M | -- |
| Diluted Shares Outstanding | 102.1M | 101.9M | 100.6M | -- | 99.8M | 98.5M | 96.3M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $421.0M | $174.0M | $214.0M | $132.9M | $307.6M | $713.5M | $433.6M | $113.4M | $100.5M | $161.1M |
| Short-Term Investments | $259.0M | $436.0M | $363.6M | $614.8M | $432.6M | $488.0M | $321.6M | $346.3M | $134.0M | $219.0M |
| **Cash & Short-Term Investments** | $680.0M | $610.0M | $577.6M | $747.8M | $740.2M | $1.20B | $755.2M | $459.7M | $234.5M | $380.1M |
| Accounts Receivable, Net | $158.0M | $122.0M | $73.39M | $40.45M | $28.43M | $23.09M | $32.84M | $12.74M | $5.17M | -- |
| Inventory | $52.00M | $45.00M | $33.97M | $26.77M | $16.23M | $13.05M | $11.55M | $7.07M | $757K | -- |
| Other Current Assets | -- | -- | $47.62M | $68.93M | -- | -- | -- | -- | -- | -- |
| **Total Current Assets** | $951.0M | $817.0M | $732.2M | $883.9M | $856.6M | $1.30B | $851.0M | $522.4M | $269.6M | $401.7M |
| Property, Plant & Equipment, Net | $244.0M | $266.0M | $290.6M | $259.7M | $141.2M | $73.52M | $44.35M | $20.05M | $21.84M | $17.05M |
| Goodwill | $44.00M | $44.00M | $44.41M | $44.41M | $44.41M | $44.41M | $44.41M | $44.41M | $44.41M | -- |
| Intangible Assets | $176.0M | $178.0M | $166.3M | $160.1M | $130.8M | $131.1M | $129.0M | $129.2M | $141.5M | -- |
| Long-Term Investments | $57.00M | $135.0M | $199.9M | $149.0M | $258.9M | $10.51M | $5.17M | -- | $9.97M | $118.0M |
| Other Non-Current Assets | $60.00M | $63.00M | $57.69M | $48.34M | $20.56M | $8.81M | $3.47M | $3.51M | $3.41M | $1.84M |
| **Total Non-Current Assets** | $581.0M | $686.0M | $758.8M | $661.5M | $665.8M | $464.3M | $284.5M | $197.2M | $221.2M | $138.9M |
| **Total Assets** | $1.53B | $1.50B | $1.49B | $1.55B | $1.52B | $1.76B | $1.14B | $719.6M | $490.8M | $540.6M |
| Accounts Payable | $31.00M | $39.00M | $42.11M | $43.27M | $17.14M | $12.92M | $12.87M | $12.28M | $8.89M | $5.36M |
| Deferred Revenue (Current) | -- | -- | -- | -- | $9.08M | $66.57M | -- | -- | $5.99M | -- |
| Other Current Liabilities | $19.00M | $4.00M | $0 | -- | -- | -- | -- | -- | -- | -- |
| **Total Current Liabilities** | $384.0M | $344.0M | $280.4M | $261.2M | $181.4M | $189.6M | $103.3M | $74.72M | $71.01M | $60.26M |
| Other Non-Current Liabilities | $44.00M | $17.00M | $12.21M | $4.82M | $1.00M | $7.35M | -- | $4.76M | $5.12M | $6.39M |
| **Total Non-Current Liabilities** | $1.22B | $897.0M | $935.2M | $931.7M | $418.5M | $415.6M | $378.4M | $35.92M | $36.28M | $6.39M |
| **Total Liabilities** | $1.60B | $1.24B | $1.22B | $1.19B | $599.8M | $605.2M | $481.7M | $110.7M | $107.3M | $66.65M |
| **Total Debt (incl. Leases)** | $36.00M | $40.34M | $43.17M | $31.59M | $41.97M | $48.23M | $36.99M | -- | -- | -- |
| Common Stock | $0 | $0 | $82K | $70K | $69K | $67K | $58K | $51K | $44K | $41K |
| Retained Earnings | -$4.53B | -$3.96B | -$3.39B | -$2.78B | -$2.07B | -$1.62B | -$1.43B | -$1.03B | -$832.7M | -$530.5M |
| Accumulated Other Comp. Income | $1.00M | -$1.00M | $647K | -$6.57M | -$1.40M | $689K | -$147K | -$633K | -$5.68M | $905K |
| **Total Stockholders' Equity** | -$80.00M | $255.0M | $275.0M | $352.0M | $922.6M | $1.15B | $653.8M | $608.9M | $383.5M | $474.0M |
| Total Equity | -$80.00M | $255.0M | $275.0M | $352.0M | $922.6M | $1.15B | $653.8M | $608.9M | $383.5M | $474.0M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $150.0M | $125.0M | $175.0M | $421.0M | $203.0M | $176.0M | $127.0M | $174.0M |
| Short-Term Investments | $116.0M | $167.0M | $238.0M | $259.0M | $222.7M | $311.3M | $367.4M | $436.0M |
| **Cash & Short-Term Investments** | $266.0M | $292.0M | $413.0M | $680.0M | $425.7M | $487.3M | $494.4M | $610.0M |
| Accounts Receivable, Net | $166.0M | $200.0M | $121.0M | $158.0M | $112.5M | $124.5M | $98.84M | $122.0M |
| Inventory | $59.00M | $59.00M | $55.00M | $52.00M | $52.20M | $46.50M | $46.03M | $45.00M |
| **Total Current Assets** | $544.0M | $606.0M | $657.0M | $951.0M | $643.2M | $719.8M | $699.2M | $817.0M |
| Property, Plant & Equipment, Net | $231.0M | $235.0M | $239.0M | $244.0M | $250.0M | $255.8M | $260.9M | $266.0M |
| Goodwill | $44.00M | $44.00M | $44.00M | $44.00M | $44.41M | $44.41M | $44.41M | $44.00M |
| Intangible Assets | $170.0M | $172.0M | $174.0M | $176.0M | $172.9M | $174.7M | $176.5M | $178.0M |
| Long-Term Investments | $135.0M | $144.0M | $121.0M | $57.00M | $22.07M | $51.45M | $68.56M | $135.0M |
| Other Non-Current Assets | $63.00M | $63.00M | $61.00M | $60.00M | $57.86M | $60.12M | $62.37M | $63.00M |
| **Total Non-Current Assets** | $643.0M | $658.0M | $639.0M | $581.0M | $547.2M | $586.5M | $612.8M | $686.0M |
| **Total Assets** | $1.19B | $1.26B | $1.30B | $1.53B | $1.19B | $1.31B | $1.31B | $1.50B |
| Accounts Payable | $45.00M | $39.00M | $42.00M | $31.00M | $40.57M | $34.24M | $47.45M | $39.00M |
| Other Current Liabilities | $22.00M | $15.00M | $17.00M | $19.00M | $1.24M | $2.58M | $3.35M | $4.00M |
| **Total Current Liabilities** | $389.0M | $351.0M | $325.0M | $384.0M | $340.0M | $293.2M | $291.7M | $344.0M |
| Other Non-Current Liabilities | $40.00M | $41.00M | $42.00M | $44.00M | $18.78M | $17.40M | $17.12M | $17.00M |
| **Total Non-Current Liabilities** | $1.17B | $1.20B | $1.20B | $1.22B | $834.3M | $854.7M | $869.0M | $897.0M |
| **Total Liabilities** | $1.56B | $1.55B | $1.52B | $1.60B | $1.17B | $1.15B | $1.16B | $1.24B |
| **Total Debt (incl. Leases)** | -- | -- | -- | $36.00M | $33.83M | $36.30M | $38.27M | $40.34M |
| Common Stock | $0 | $0 | $0 | $0 | $96K | $96K | $94K | $0 |
| Retained Earnings | -$4.93B | -$4.81B | -$4.72B | -$4.53B | -$4.40B | -$4.22B | -$4.11B | -$3.96B |
| Accumulated Other Comp. Income | -$1.00M | $0 | $0 | $1.00M | $820K | -$268K | -$341K | -$1.00M |
| **Total Stockholders' Equity** | -$376.0M | -$291.0M | -$236.0M | -$80.00M | $10.00M | $151.0M | $144.0M | $255.0M |
| Total Equity | -$376.0M | -$291.0M | -$236.0M | -$80.00M | $10.00M | $151.0M | $144.0M | $255.0M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$575.0M | -$569.0M | -$607.0M | -$707.4M | -$454.0M | -$186.6M | -$402.7M | -$197.6M | -$302.1M | -$245.9M |
| Depreciation & Amortization | $35.00M | $36.00M | $26.00M | $18.22M | $13.24M | $12.26M | $8.54M | $19.54M | $5.83M | $3.42M |
| Stock-Based Compensation | $153.0M | $158.0M | $135.0M | $130.4M | $105.0M | $85.73M | $82.00M | $80.11M | $68.01M | $48.31M |
| Change in Receivables | -$31.00M | -$34.00M | -$23.00M | -$12.07M | -$5.43M | $9.84M | -$20.10M | -$7.58M | -$5.17M | -- |
| Change in Inventory | -$6.00M | -$11.00M | -$7.00M | -$9.70M | -$3.12M | -$1.35M | -$4.45M | -$5.28M | -$757K | -- |
| Change in Payables | -- | -- | -- | -- | -- | -- | -- | $3.37M | $3.46M | $2.50M |
| **Operating Cash Flow** | -$466.0M | -$414.0M | -$475.0M | -$380.5M | -$338.7M | -$132.2M | -$345.4M | -$290.6M | -$253.8M | -$161.0M |
| Capital Expenditure | -$6.00M | -$7.00M | -$44.00M | -$116.1M | -$73.09M | -$43.91M | -$24.83M | -$4.08M | -$2.79M | -$10.19M |
| **Free Cash Flow** | -$472.0M | -$421.0M | -$519.0M | -$496.6M | -$411.8M | -$176.1M | -$370.2M | -$294.6M | -$256.6M | -$171.2M |
| Acquisitions, Net | -- | $0 | $0 | -$75.03M | $0 | $0 | -- | -- | -$142.8M | -- |
| Purchases of Investments | -$186.0M | -$409.0M | -$526.0M | -$614.7M | -$1.01B | -$813.2M | -$692.8M | -$509.8M | -- | -- |
| Sales & Maturities of Investments | $444.0M | $413.0M | $747.0M | $535.0M | $811.0M | $640.8M | $719.0M | $310.2M | -- | -- |
| **Investing Cash Flow** | $236.0M | -$18.00M | $168.0M | -$291.7M | -$195.4M | -$179.1M | -$13.04M | -$33.33M | $55.48M | $91.12M |
| Common Stock Issued | -- | -- | -- | $0 | $0 | $435.6M | $330.4M | $271.0M | -- | -- |
| **Financing Cash Flow** | $478.0M | $399.0M | $388.0M | $501.2M | $118.6M | $600.3M | $679.3M | $336.9M | $136.3M | $138.7M |
| **Net Change in Cash** | $252.0M | -$35.00M | $81.00M | -$172.0M | -$416.7M | $290.1M | $320.7M | $12.48M | -$61.57M | $68.75M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$118.0M | -$92.00M | -$185.0M | -$129.0M | -$180.0M | -$115.0M | -$151.0M | -$133.2M |
| Depreciation & Amortization | $9.00M | $8.00M | $8.00M | $9.00M | $8.00M | $9.00M | $9.00M | $9.54M |
| Stock-Based Compensation | $34.00M | $34.00M | $30K | $37.00M | $37.00M | $39.00M | $40K | $40.13M |
| Change in Receivables | $23.00M | -$62.00M | $19.00M | -$34.00M | $6.00M | -$13.00M | $10.00M | -$21.04M |
| Change in Inventory | -$1.00M | -$3.00M | -$4.00M | $0 | -$5.00M | $0 | -$1.00M | -$2.25M |
| **Operating Cash Flow** | -$43.00M | -$97.00M | -$197.0M | -$100.0M | -$91.00M | -$109.0M | -$166.0M | -$79.31M |
| Capital Expenditure | -$2.00M | -$1.00M | -$1.00M | -$1.00M | -$1.00M | -$3.00M | -$1.00M | -$163K |
| **Free Cash Flow** | -$45.00M | -$98.00M | -$198.0M | -$101.0M | -$92.00M | -$112.0M | -$167.0M | -$79.48M |
| Purchases of Investments | -$39.00M | -$57.00M | -$131.0M | -$154.0M | -$16.00M | -$16.00M | $0 | -$16.32M |
| Sales & Maturities of Investments | -- | -- | -- | $82.00M | $136.0M | $88.91M | $137.1M | $119.2M |
| **Investing Cash Flow** | $58.00M | $44.00M | -$49.00M | -$72.00M | $117.0M | $71.00M | $120.0M | $102.5M |
| **Financing Cash Flow** | -- | -- | -- | $394.0M | $0 | $83.84M | $157K | $2.94M |
| **Net Change in Cash** | $24.00M | -$49.00M | -$247.0M | $221.0M | $26.00M | $50.00M | -$45.00M | $24.18M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Gross Margin** | -- | -- | -- | -- | -- | -- | -- | 97.8% | 100.0% | -- |
| **Operating Margin** | -79.5% | -95.7% | -131.1% | -178.6% | -108.6% | -121.8% | -409.0% | -721.2% | -12593.5% | -186471.4% |
| **Net Profit Margin** | -85.4% | -101.6% | -139.9% | -194.7% | -129.2% | -68.8% | -388.3% | -383.7% | -11567.3% | -184867.7% |
| Return on Equity (ROE) | -- | -223.1% | -220.7% | -201.0% | -49.2% | -16.2% | -61.6% | -32.5% | -78.8% | -51.9% |
| Return on Assets (ROA) | -37.5% | -37.9% | -40.7% | -45.8% | -29.8% | -10.6% | -35.5% | -27.5% | -61.6% | -45.5% |
| Current Ratio | 2.48x | 2.38x | 2.61x | 3.38x | 4.72x | 6.83x | 8.24x | 6.99x | 3.80x | 6.67x |
| Quick Ratio | 2.34x | 2.24x | 2.49x | 3.28x | 4.63x | 6.76x | 8.13x | 6.90x | 3.79x | 6.31x |
| Debt to Equity | -- | 0.16x | 0.16x | 0.09x | 0.05x | 0.04x | 0.06x | -- | -- | -- |
| **Revenue Growth (YoY)** | +20.2% | +29.0% | +19.5% | +3.4% | +29.7% | +161.3% | +101.4% | +1871.5% | +1863.9% | -- |
| Gross Profit Growth (YoY) | -- | -- | -- | -- | -- | -- | -- | +1828.3% | -- | -- |
| 5Y Revenue / Share Growth | +53.2% | +237.6% | +470.8% | +8346.4% | +154179.4% | -- | -- | -- | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Operating Margin** | -64.0% | -73.6% | -83.7% | -79.5% | -86.3% | -82.8% | -87.0% | -95.7% |
| **Net Profit Margin** | -71.8% | -81.7% | -90.9% | -85.4% | -91.8% | -87.3% | -93.1% | -101.6% |
| Return on Equity (ROE) | -- | -- | -- | -- | -5792.0% | -352.8% | -381.5% | -223.1% |
| Return on Assets (ROA) | -44.1% | -46.4% | -47.0% | -37.5% | -48.7% | -40.8% | -41.9% | -37.9% |
| Current Ratio | 1.40x | 1.73x | 2.02x | 2.48x | 1.89x | 2.45x | 2.40x | 2.38x |
| Quick Ratio | 1.25x | 1.56x | 1.85x | 2.34x | 1.74x | 2.30x | 2.24x | 2.24x |
| Debt to Equity | -- | -- | -- | -- | 3.38x | 0.24x | 0.27x | 0.16x |
| **Revenue Growth (YoY)** | +8.1% | +28.1% | -2.2% | +25.7% | +14.7% | +13.6% | +27.7% | +29.5% |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
